SUPERNUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.62 USD | +0.46% |
|
+9.95% | -1.11% |
| Jul. 01 | Supernus Pharmaceuticals, Inc.(NasdaqGM:SUPN) added to Russell Small Cap Comp Value Index | CI |
| Jul. 01 | Supernus Pharmaceuticals, Inc.(NasdaqGM:SUPN) added to Russell 2500 Value Index | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-07-09 | 2024-07-10 | 2024-07-11 | 2024-07-12 | |
|---|---|---|---|---|
| Last | 26.69 $ | 27.48 $ | 28.49 $ | 28.62 $ |
| Volume | 270 137 | 286 574 | 466 369 | 472 320 |
| Change | +1.71% | +2.96% | +3.68% | +0.46% |
| Opening | 26.18 | 26.74 | 28.03 | 28.88 |
| High | 26.76 | 27.49 | 28.60 | 29.62 |
| Low | 26.08 | 26.65 | 27.80 | 28.47 |
Performance
| 1 day | +0.46% | ||
| 1 week | +9.95% | ||
| Current month | +6.99% | ||
| 1 month | +5.69% | ||
| 3 months | -5.36% | ||
| 6 months | +1.35% | ||
| Current year | -1.11% | ||
| 1 year | -6.16% | ||
| 3 years | +1.35% | ||
| 5 years | -10.28% | ||
| 10 years | +172.05% |
Volumes
marketsDaily volume
472 320
Estimated daily volume
472 320
Avg. Volume 20 sessions
730 251
Daily volume ratio
0.65
Avg. Volume 20 sessions USD
20 899 783.62
Record volume 1
11 208 680
Record volume 2
6 737 648
Record volume 3
6 644 855
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
1 573 363 149
Net sales (USD)
607 521 000
Number of employees
652
Sales / Employee (USD)
931 781
Free-Float
94.98 %
Free-Float capitalization (USD)
1 494 380 048
Average Daily Capital Traded
1.33%
Highs and lows
1 week
25.94
29.62
1 month
25.5329.62
Current year
25.5335.44
1 year
21.9935.44
3 years
21.9942.09
5 years
13.1242.09
10 years
7.3161.25
Indicators
Moving average 5 days
27.50
Moving average 20 days
26.66
Moving average 50 days
27.76
Moving average 100 days
29.60
Price spread / (MMA5)
-3.90%
Price spread / (MMA20)
-6.86%
Price spread / (MMA50)
-3.00%
Price spread / (MMA100)
+3.44%
STIM
RSI 9 days
73.72
RSI 14 days
63.78
Sector Comparison - Specialty & Advanced Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.46% | +9.95% | -1.11% | -6.16% | 1.57B | ||
| +0.59% | +1.08% | +7.04% | +3.04% | 73.13B | ||
| +0.19% | +6.77% | +31.10% | +20.66% | 10.38B | ||
| +7.47% | +6.03% | +37.94% | +68.04% | 5.16B | ||
| +3.36% | +5.06% | -17.33% | +12.62% | 4.73B | ||
| +2.14% | -2.64% | +21.49% | +50.92% | 3.81B | ||
| +2.34% | +12.51% | +24.92% | +12.10% | 2.26B | ||
| -0.06% | -0.88% | -36.84% | -35.86% | 1.88B | ||
| -1.37% | -0.22% | -43.31% | -47.29% | 1.77B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| +3.07% | +1.75% | +89.37% | +109.86% | 1.21B | ||
| +0.67% | +3.97% | -13.37% | -2.01% | 1.11B | ||
| -0.10% | +0.10% | +61.92% | +139.44% | 1.06B | ||
| +1.62% | +2.45% | -20.09% | -19.69% | 978M | ||
| +0.15% | +2.04% | +5.34% | +11.89% | 911M | ||
| +0.61% | +13.55% | -7.65% | +31.57% | 846M | ||
| Average | +1.32% | +5.32% | +9.29% | +23.28% | ||
| Weighted average by Cap. | +1.05% | +2.80% | +9.74% | +10.87% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
53c6beaea.KCHxnk_m2PkflBuHQ_5qhBfbvjEejc6-TDCU9KA-ITI.YkaAyC6PuaoyxV3UErIv0mSU_19G5o_UI0XSmPhIfmhpZrjcLtKXrXTGLw
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 28.62 | 64,364 | 304,567 |
| 03:59:59 pm | 28.66 | 100 | 240,203 |
| 03:59:59 pm | 28.66 | 156 | 240,103 |
| 03:59:59 pm | 28.66 | 100 | 239,947 |
| 03:59:59 pm | 28.65 | 100 | 239,847 |
| 03:59:59 pm | 28.65 | 600 | 239,747 |
| 03:59:59 pm | 28.7 | 100 | 239,147 |
| 03:59:59 pm | 28.7 | 100 | 239,047 |
| 03:59:59 pm | 28.64 | 100 | 238,947 |
| 03:59:55 pm | 28.64 | 100 | 238,847 |
Monthly variations
Annual change
| 2024 | -1.11% | ||
| 2023 | -18.87% | ||
| 2022 | +22.33% | ||
| 2021 | +15.90% | ||
| 2020 | +6.07% | ||
| 2019 | -28.60% | ||
| 2018 | -16.64% | ||
| 2017 | +57.82% | ||
| 2016 | +87.87% | ||
| 2015 | +61.93% | ||
| 2014 | +10.08% | ||
| 2013 | +5.16% | ||
| 2012 | +33.52% |
- Stock Market
- Equities
- SUPN Stock
- Quotes Supernus Pharmaceuticals, Inc.
